drugset / Trial / NCT00160264

Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal Women

NCT00160264

Phase 4 Completed 40 enrolled Solvay Pharmaceuticals
RandomizedParallel-groupDouble-blind

Summary

This is a randomized, double-blind, multicentre, parallel pilot clinical trial to study the efficacy of a treatment of lactulose 15 ml + vitamin D 400 U + calcium 0.5 g compared to lactulose placebo 15 ml + vitamin D 400 U + calcium 1 g in bone mass preservation among postmenopausal women.

Timeline

Start
2003-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcium carbonate Other / unclassified 0.5 g
Subject Calcium carbonate Other / unclassified 1 g
Subject Lactulose Other / unclassified 15 ml
Background Vitamin D Other / unclassified 400 iu

Indications